1.Dual Mechanism of Action: YK11 combines the properties of a SARM with those of a myostatin inhibitor. By binding to androgen receptors, it promotes muscle growth, and by increasing follistatin levels, it inhibits myostatin, a protein that restricts muscle growth.
2.Steroidal Structure: Unlike many non-steroidal SARMs, YK11 possesses a steroidal backbone, which may contribute to its potent anabolic effects.
3.Partial Agonist: As a partial agonist of the androgen receptor, YK11 activates the receptor but not to its full capacity, potentially reducing the risk of some side effects associated with full agonists.
